![]() |
Stanford enrolling CRPS patients for LDN study
From the Stanford Medicine: Systems Neuroscience and Pain Lab:
"Low-Dose Naltrexone (LDN) for the Treatment of Complex Regional Pain Syndrome (CRPS) is currently enrolling participants." Here's the link: CRPS Treatment Study | Systems Neuroscience and Pain Lab | Stanford Medicine |
did any one sign up for the study?
|
All times are GMT -5. The time now is 07:29 PM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.